Skip to content
Biodatica
Start free

Investigator

Gavin R Rumbaugh

NORTHWESTERN UNIVERSITY · funded by NIMH

Companies
2

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$3.0M

Summed across those awards.

First award
Sep 12, 2012

Latest May 1, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. P50

    Regulation of in vivo cortical circuit function and behavior by synaptic GEFs and GAPs

    $717k

    May 1, 2024NIMHNORTHWESTERN UNIVERSITYNIH RePORTER · 11077235 (opens the source filing in a new tab)

  2. P50

    Regulation of in vivo cortical circuit function and behavior by synaptic GEFs and GAPs

    $717k

    May 1, 2024NIMHNORTHWESTERN UNIVERSITYNIH RePORTER · 11418331 (opens the source filing in a new tab)

  3. R01

    Neurodevelopmental Disorder Risk Gene Regulation of Intrinsic Membrane Excitability: A Rheostat that Tunes Dendritic Morphogenesis to Regulate Circuit Assembly During Development

    $678k

    Sep 1, 2022NIMHUNIVERSITY OF FLORIDANIH RePORTER · 11140431 (opens the source filing in a new tab)

  4. R01

    Intersection of causal neurodevelopmental disorder risk genes, cortical circuit function, and cognitive processing required for behavioral adaptions

    $891k

    Sep 12, 2012NIMHUNIVERSITY OF FLORIDANIH RePORTER · 11235870 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources